SCOPUS 정보 검색 플랫폼

Bioorganic and Medicinal Chemistry Letters

Volumn 23, Issue 12, 2013, Pages 3570-3575

Carbonic anhydrase inhibitors. Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydrase

(9) Alafeefy, Ahmed M a Isik, Semra b Al Jaber, Nabila A c Vullo, Daniela b Abdel Aziz, Hatem A d Ashour, Abdelkader E d Awaad, Amani S c Capasso, Clemente e Supuran, Claudiu T b

a PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY (Saudi Arabia)

b UNIVERSITY OF FLORENCE (Italy)

c KING SAUD UNIVERSITY (Saudi Arabia)

d KING SAUD UNIVERSITY (Saudi Arabia)

e INSTITUTE OF PROTEIN BIOCHEMISTRY (Italy)

Author keywords

Antifungals; Carbonic anhydrase; Cyanoacrylamide; Saccharomyces cerevisiae; Sulfonamide

Indexed keywords

ACETAZOLAMIDE; ACRYLAMIDE DERIVATIVE; ANTIFUNGAL AGENT; BENZENESULFONAMIDE DERIVATIVE; BETA CARBONIC ANHYDRASE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CYANOACRYLAMIDE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; FUNGAL STRAIN; GROWTH INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; SACCHAROMYCES CEREVISIAE;

ANTIFUNGAL AGENTS; CARBONIC ANHYDRASE INHIBITORS; HUMANS; SACCHAROMYCES CEREVISIAE; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

SACCHAROMYCES CEREVISIAE;

EID: 84878109869 PISSN: 0960894X EISSN: 14643405 Source Type: Journal
DOI: 10.1016/j.bmcl.2013.04.028 Document Type: Article

Times cited : (19)

References (46)

1
- 76849115056
- S. Elleuche, and S. Pöggeler Microbiology 156 2010 23
- (2010) Microbiology , vol.156 , pp. 23
- Elleuche, S.¹ Pöggeler, S.²

2
- 27844459081
- T. Klengel, W.J. Liang, J. Chaloupka, C. Ruoff, K. Schropel, J.R. Naglik, S.E. Eckert, E.G. Mogensen, K. Haynes, M.F. Tuite, L.R. Levin, J. Buck, and F.A. Mühlschlegel Curr. Biol. 15 2005 2021
- (2005) Curr. Biol. , vol.15 , pp. 2021
- Klengel, T.¹ Liang, W.J.² Chaloupka, J.³ Ruoff, C.⁴ Schropel, K.⁵ Naglik, J.R.⁶ Eckert, S.E.⁷ Mogensen, E.G.⁸ Haynes, K.⁹ Tuite, M.F.¹⁰ Levin, L.R.¹¹ Buck, J.¹² Mühlschlegel, F.A.¹³

3
- 27844610829
- Y.S. Bahn, G.M. Cox, J.R. Perfect, and J. Heitman Curr. Biol. 15 2005 2013
- (2005) Curr. Biol. , vol.15 , pp. 2013
- Bahn, Y.S.¹ Cox, G.M.² Perfect, J.R.³ Heitman, J.⁴

4
- 30944437608
- E.G. Mogensen, G. Janbon, J. Chaloupka, C. Steegborn, M.S. Fu, F. Moyrand, T. Klengel, D.S. Pearson, M.A. Geeves, J. Buck, L.R. Levin, and F.A. Mühlschlegel Eukaryotic Cell 5 2006 103
- (2006) Eukaryotic Cell , vol.5 , pp. 103
- Mogensen, E.G.¹ Janbon, G.² Chaloupka, J.³ Steegborn, C.⁴ Fu, M.S.⁵ Moyrand, F.⁶ Klengel, T.⁷ Pearson, D.S.⁸ Geeves, M.A.⁹ Buck, J.¹⁰ Levin, L.R.¹¹ Mühlschlegel, F.A.¹²

5
- 33751257469
- Y.S. Bahn, and F.A. Mühlschlegel Curr. Opin. Microbiol. 9 2006 572
- (2006) Curr. Opin. Microbiol. , vol.9 , pp. 572
- Bahn, Y.S.¹ Mühlschlegel, F.A.²

6
- 67651168095
- C.T. Supuran, J.Y. Winum, John Wiley & Sons Hoboken
- R.A. Hall, and F.A. Mühlschlegel C.T. Supuran, J.Y. Winum, Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications 2009 John Wiley & Sons Hoboken 301 322
- (2009) Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications , pp. 301-322
- Hall, R.A.¹ Mühlschlegel, F.A.²

7
- 79952454295
- C.T. Supuran, J.Y. Winum, John Wiley & Sons Hoboken
- U.M. Ohndorf, C. Schlicker, and C. Steegborn C.T. Supuran, J.Y. Winum, Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications 2009 John Wiley & Sons Hoboken 323 334
- (2009) Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications , pp. 323-334
- Ohndorf, U.M.¹ Schlicker, C.² Steegborn, C.³

8
- 67651162210
- A. Innocenti, W. Leewattanapasuk, F.A. Mühlschlegel, A. Mastrolorenzo, and C.T. Supuran Bioorg. Med. Chem. Lett. 19 2009 4802
- (2009) Bioorg. Med. Chem. Lett. , vol.19 , pp. 4802
- Innocenti, A.¹ Leewattanapasuk, W.² Mühlschlegel, F.A.³ Mastrolorenzo, A.⁴ Supuran, C.T.⁵

9
- 58149330109
- C. Schlicker, R.A. Hall, D. Vullo, S. Middelhaufe, M. Gertz, C.T. Supuran, F.A. Muhlschlegel, and C. Steegborn J. Mol. Biol. 385 2009 1207
- (2009) J. Mol. Biol. , vol.385 , pp. 1207
- Schlicker, C.¹ Hall, R.A.² Vullo, D.³ Middelhaufe, S.⁴ Gertz, M.⁵ Supuran, C.T.⁶ Muhlschlegel, F.A.⁷ Steegborn, C.⁸

10
- 72249101494
- Y.B. Teng, Y.L. Jiang, Y.X. He, W.W. He, F.M. Lian, Y. Chen, and C.Z. Zhou BMC Struct. Biol. 9 2009 67
- (2009) BMC Struct. Biol. , vol.9 , pp. 67
- Teng, Y.B.¹ Jiang, Y.L.² He, Y.X.³ He, W.W.⁴ Lian, F.M.⁵ Chen, Y.⁶ Zhou, C.Z.⁷

11
- 84874514654
- F. Cottier, W. Leewattanapasuk, L.R. Kemp, M. Murphy, C.T. Supuran, O. Kurzai, and F.A. Mühlschlegel Bioorg. Med. Chem. 21 2013 1549
- (2013) Bioorg. Med. Chem. , vol.21 , pp. 1549
- Cottier, F.¹ Leewattanapasuk, W.² Kemp, L.R.³ Murphy, M.⁴ Supuran, C.T.⁵ Kurzai, O.⁶ Mühlschlegel, F.A.⁷

12
- 84857473389
- F. Cottier, M. Raymond, O. Kurzai, M. Bolstad, W. Leewattanapasuk, C. Jiménez-López, M.C. Lorenz, D. Sanglard, L. Váchová, N. Pavelka, Z. Palková, and F.A. Mühlschlegel PLoS Pathogens 8 2012 e1002485
- (2012) PLoS Pathogens , vol.8 , pp. 1002485
- Cottier, F.¹ Raymond, M.² Kurzai, O.³ Bolstad, M.⁴ Leewattanapasuk, W.⁵ Jiménez-López, C.⁶ Lorenz, M.C.⁷ Sanglard, D.⁸ Váchová, L.⁹ Pavelka, N.¹⁰ Palková, Z.¹¹ Mühlschlegel, F.A.¹²

13
- 84855658697
- S.M. Monti, A. Maresca, F. Carta, G. De Simone, F.A. Mühlschlegel, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. Lett. 22 2012 859
- (2012) Bioorg. Med. Chem. Lett. , vol.22 , pp. 859
- Monti, S.M.¹ Maresca, A.² Carta, F.³ De Simone, G.⁴ Mühlschlegel, F.A.⁵ Scozzafava, A.⁶ Supuran, C.T.⁷

14
- 56249144470
- S. Isik, F. Kockar, O. Arslan, O.O. Guler, A. Innocenti, and C.T. Supuran Bioorg. Med. Chem. Lett. 18 2008 6327
- (2008) Bioorg. Med. Chem. Lett. , vol.18 , pp. 6327
- Isik, S.¹ Kockar, F.² Arslan, O.³ Guler, O.O.⁴ Innocenti, A.⁵ Supuran, C.T.⁶

15
- 58949104723
- S. Isik, F. Kockar, M.O. Aydin, Arslan, O.O. Guler, A. Innocenti, A. Scozzafava, and C.T. Supuran Bioorg. Med. Chem. 17 2009 1158
- (2009) Bioorg. Med. Chem. , vol.17 , pp. 1158
- Isik, S.¹ Kockar, F.² Aydin, M.O.³ Arslan⁴ Guler, O.O.⁵ Innocenti, A.⁶ Scozzafava, A.⁷ Supuran, C.T.⁸

16
- 78649850033
- S. Isik, O.O. Guler, F. Kockar, M. Aydin, O. Arslan, and C.T. Supuran Curr. Pharm. Des. 16 2010 3327
- (2010) Curr. Pharm. Des. , vol.16 , pp. 3327
- Isik, S.¹ Guler, O.O.² Kockar, F.³ Aydin, M.⁴ Arslan, O.⁵ Supuran, C.T.⁶

17
- 84859797119
- K.S. Hewitson, D. Vullo, A. Scozzafava, A. Mastrolorenzo, and C.T. Supuran J. Med. Chem. 55 2012 3513
- (2012) J. Med. Chem. , vol.55 , pp. 3513
- Hewitson, K.S.¹ Vullo, D.² Scozzafava, A.³ Mastrolorenzo, A.⁴ Supuran, C.T.⁵

18
- 84863501358
- V. Alterio, A. Di Fiore, K. D'Ambrosio, C.T. Supuran, and G. De Simone Chem. Rev. 112 2012 4421
- (2012) Chem. Rev. , vol.112 , pp. 4421
- Alterio, V.¹ Di Fiore, A.² D'Ambrosio, K.³ Supuran, C.T.⁴ De Simone, G.⁵

19
- 38849143765
- C.T. Supuran Nat. Rev. Drug Discov. 7 2008 168
- (2008) Nat. Rev. Drug Discov. , vol.7 , pp. 168
- Supuran, C.T.¹

20
- 84865850354
- C.T. Supuran J. Enzyme Inhib. Med. Chem. 27 2012 759
- (2012) J. Enzyme Inhib. Med. Chem. , vol.27 , pp. 759
- Supuran, C.T.¹

21
- 84878089506
- C.T. Supuran J. Enzyme Inhib. Med. Chem. 28 2013 229
- (2013) J. Enzyme Inhib. Med. Chem. , vol.28 , pp. 229
- Supuran, C.T.¹

22
- 77954218410
- C.T. Supuran Bioorg. Med. Chem. Lett. 20 2010 3467
- (2010) Bioorg. Med. Chem. Lett. , vol.20 , pp. 3467
- Supuran, C.T.¹

23
- 3442883664
- S. Pastorekova, S. Parkkila, J. Pastorek, and C.T. Supuran J. Enzyme Inhib. Med. Chem. 19 2004 199
- (2004) J. Enzyme Inhib. Med. Chem. , vol.19 , pp. 199
- Pastorekova, S.¹ Parkkila, S.² Pastorek, J.³ Supuran, C.T.⁴

24
- 0032710065
- B.W. Clare, and C.T. Supuran Eur. J. Med. Chem. 34 1999 463
- (1999) Eur. J. Med. Chem. , vol.34 , pp. 463
- Clare, B.W.¹ Supuran, C.T.²

25
- 81355149286
- F. Bootorabi, J. Jänis, V.P. Hytönen, J. Valjakka, M. Kuuslahti, D. Vullo, O. Niemelä, C.T. Supuran, and S. Parkkila J. Enzyme Inhib. Med. Chem. 26 2011 862
- (2011) J. Enzyme Inhib. Med. Chem. , vol.26 , pp. 862
- Bootorabi, F.¹ Jänis, J.² Hytönen, V.P.³ Valjakka, J.⁴ Kuuslahti, M.⁵ Vullo, D.⁶ Niemelä, O.⁷ Supuran, C.T.⁸ Parkkila, S.⁹

26
- 79961070760
- C.T. Supuran Future Med. Chem. 3 2011 1165
- (2011) Future Med. Chem. , vol.3 , pp. 1165
- Supuran, C.T.¹

27
- 0037369153
- C.T. Supuran, A. Scozzafava, and A. Casini Med. Res. Rev. 23 2003 146
- (2003) Med. Res. Rev. , vol.23 , pp. 146
- Supuran, C.T.¹ Scozzafava, A.² Casini, A.³

28
- 33750471952
- B.L. Wilkinson, L.F. Bornaghi, T.A. Houston, A. Innocenti, C.T. Supuran, and S.A. Poulsen J. Med. Chem. 49 2006 6539
- (2006) J. Med. Chem. , vol.49 , pp. 6539
- Wilkinson, B.L.¹ Bornaghi, L.F.² Houston, T.A.³ Innocenti, A.⁴ Supuran, C.T.⁵ Poulsen, S.A.⁶

29
- 1242303231
- C.T. Supuran, A. Scozzafava, J. Conway, CRC Press Boca Raton (FL, USA)
- C.T. Supuran, A. Scozzafava, and A. Casini C.T. Supuran, A. Scozzafava, J. Conway, Carbonic Anhydrase - Its Inhibitors and Activators 2004 CRC Press Boca Raton (FL, USA) 67 147
- (2004) Carbonic Anhydrase - Its Inhibitors and Activators , pp. 67-147
- Supuran, C.T.¹ Scozzafava, A.² Casini, A.³

30
- 84891563824
- J.U. Peters, Wiley Hoboken
- C.T. Supuran J.U. Peters, Polypharmacology in Drug Discovery 2012 Wiley Hoboken 459 491
- (2012) Polypharmacology in Drug Discovery , pp. 459-491
- Supuran, C.T.¹

31
- 84862900393
- F. Carta, A. Scozzafava, and C.T. Supuran Expert Opin. Ther. Patents 22 2012 747
- (2012) Expert Opin. Ther. Patents , vol.22 , pp. 747
- Carta, F.¹ Scozzafava, A.² Supuran, C.T.³

32
- 84864247302
- M. Aggarwal, and R. McKenna Expert Opin. Ther. Patents 22 2012 903
- (2012) Expert Opin. Ther. Patents , vol.22 , pp. 903
- Aggarwal, M.¹ McKenna, R.²

33
- 79952049866
- C. Calugi, A. Trabocchi, and A. Guarna Expert Opin. Ther. Patents 21 2011 381
- (2011) Expert Opin. Ther. Patents , vol.21 , pp. 381
- Calugi, C.¹ Trabocchi, A.² Guarna, A.³

34
- 0344923836
- P.L. Fidel Jr., J.A. Vazquez, and J.D. Sobel Clin. Microbiol. Rev. 12 1999 80
- (1999) Clin. Microbiol. Rev. , vol.12 , pp. 80
- Fidel Jr., P.L.¹ Vazquez, J.A.² Sobel, J.D.³

35
- 22544444651
- R. Kaur, R. Domergue, M.L. Zupancic, and B.P. Cormack Curr. Opin. Microbiol. 8 2005 378
- (2005) Curr. Opin. Microbiol. , vol.8 , pp. 378
- Kaur, R.¹ Domergue, R.² Zupancic, M.L.³ Cormack, B.P.⁴

36
- 33846025137
- M. Pai, R. Turpin, and K. Garey Antimicrob. Agents Chemother. 51 2007 35
- (2007) Antimicrob. Agents Chemother. , vol.51 , pp. 35
- Pai, M.¹ Turpin, R.² Garey, K.³

37
- 0036550465
- V. Krcmery, and A.J. Barnes J. Hosp. Infect. 50 2002 243
- (2002) J. Hosp. Infect. , vol.50 , pp. 243
- Krcmery, V.¹ Barnes, A.J.²

38
- 2142810157
- J.E. Bennett, K. Izumikawa, and K.A. Marr Antimicrob. Agents Chemother. 48 2004 1773
- (2004) Antimicrob. Agents Chemother. , vol.48 , pp. 1773
- Bennett, J.E.¹ Izumikawa, K.² Marr, K.A.³

39
- 0027320369
- C.A. Hitchcock, G.W. Pye, P.F. Troke, E.M. Johnson, and D.W. Warnock Antimicrob. Agents Chemother. 37 1993 1962
- (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 1962
- Hitchcock, C.A.¹ Pye, G.W.² Troke, P.F.³ Johnson, E.M.⁴ Warnock, D.W.⁵

40
- 52649101465
- M.E. Fadda, G.S. Podda, M.B. Pisano, M. Deplano, and S. Cosentino J. Prev. Med. Hyg. 49 2008 69
- (2008) J. Prev. Med. Hyg. , vol.49 , pp. 69
- Fadda, M.E.¹ Podda, G.S.² Pisano, M.B.³ Deplano, M.⁴ Cosentino, S.⁵

41
- 77954936508
- I. Stefanini, A. Trabocchi, E. Marchi, A. Guarna, and D. Cavalieri J. Biol. Chem. 285 2010 23477
- (2010) J. Biol. Chem. , vol.285 , pp. 23477
- Stefanini, I.¹ Trabocchi, A.² Marchi, E.³ Guarna, A.⁴ Cavalieri, D.⁵

42
- 78649514179
- A. Trabocchi, I. Stefanini, M. Morvillo, L. Ciofi, D. Cavalieri, and A. Guarna Org. Biomol. Chem. 8 2010 5552
- (2010) Org. Biomol. Chem. , vol.8 , pp. 5552
- Trabocchi, A.¹ Stefanini, I.² Morvillo, M.³ Ciofi, L.⁴ Cavalieri, D.⁵ Guarna, A.⁶

43
- 84874530715
- A.M. Alafeefy, S. Isik, H.A. Abdel-Aziz, A.E. Ashour, D. Vullo, N.A. Al-Jaber, and C.T. Supuran Bioorg. Med. Chem. 21 2013 1396
- (2013) Bioorg. Med. Chem. , vol.21 , pp. 1396
- Alafeefy, A.M.¹ Isik, S.² Abdel-Aziz, H.A.³ Ashour, A.E.⁴ Vullo, D.⁵ Al-Jaber, N.A.⁶ Supuran, C.T.⁷

44
- 0015239422
- 2 concentrations ranged from 1.7 to 17 mM for the determination of the kinetic parameters and inhibition constants. For each inhibitor at least six traces of the initial 5-10% of the reaction have been used for determining the initial velocity. The uncatalyzed rates were determined in the same manner and subtracted from the total observed rates.
- 7,12 The concentration of the enzymes in the assays was of 8.3 nM for hCA I, of 5.7 nM for hCA II, and of 12.1 nM for ScCA, respectively.
- (1971) J. Biol. Chem. , vol.246 , pp. 2561
- Khalifah, R.J.¹

45
- 84863424129
- J.Y. Winum, F. Carta, C. Ward, P. Mullen, D. Harrison, S.P. Langdon, A. Cecchi, A. Scozzafava, I. Kunkler, and C.T. Supuran Bioorg. Med. Chem. Lett. 22 2012 4681
- (2012) Bioorg. Med. Chem. Lett. , vol.22 , pp. 4681
- Winum, J.Y.¹ Carta, F.² Ward, C.³ Mullen, P.⁴ Harrison, D.⁵ Langdon, S.P.⁶ Cecchi, A.⁷ Scozzafava, A.⁸ Kunkler, I.⁹ Supuran, C.T.¹⁰

46
- 77954874450
- L. Syrjänen, M. Tolvanen, M. Hilvo, A. Olatubosun, A. Innocenti, A. Scozzafava, J. Leppiniemi, B. Niederhauser, V.P. Hytönen, T.A. Gorr, S. Parkkila, and C.T. Supuran BMC Biochem. 11 2010 28
- (2010) BMC Biochem. , vol.11 , pp. 28
- Syrjänen, L.¹ Tolvanen, M.² Hilvo, M.³ Olatubosun, A.⁴ Innocenti, A.⁵ Scozzafava, A.⁶ Leppiniemi, J.⁷ Niederhauser, B.⁸ Hytönen, V.P.⁹ Gorr, T.A.¹⁰ Parkkila, S.¹¹ Supuran, C.T.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.